Targeted treatment in viral-associated inflammatory cardiomyopathy.
Human herpesvirus 6
heart failure
inflammatory cardiomyopathy
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
01
04
2021
revised:
15
05
2021
accepted:
09
06
2021
entrez:
29
7
2021
pubmed:
30
7
2021
medline:
30
7
2021
Statut:
epublish
Résumé
Detection of viruses like HHV-6 in endomyocardial biopsy or serum serology of patients with myocarditis or heart failure features unresponsive to conventional heart failure therapies could be a potential targeted treatment especially in refractory cases.
Identifiants
pubmed: 34322262
doi: 10.1002/ccr3.4518
pii: CCR34518
pmc: PMC8299269
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04518Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
Intervirology. 2016;59(3):143-151
pubmed: 28081531
Curr Opin Cardiol. 2018 May;33(3):325-333
pubmed: 29528906
Swiss Med Wkly. 2014 Oct 02;144:w14010
pubmed: 25275335
J Am Coll Cardiol. 2016 Nov 29;68(21):2348-2364
pubmed: 27884253
Herz. 2018 Aug;43(5):423-430
pubmed: 29947834
J Am Coll Cardiol. 2012 Oct 2;60(14):1295-6
pubmed: 23017536
J Clin Virol. 2015 Feb;63:1-5
pubmed: 25600595
Eur J Heart Fail. 2015 Jan;17(1):9-19
pubmed: 25388833
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):178-87
pubmed: 26795929
N Engl J Med. 2010 Apr 1;362(13):1248-9
pubmed: 20357294
Nat Rev Cardiol. 2021 Mar;18(3):169-193
pubmed: 33046850
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828